CTT Pharmaceutical Holdings, Inc. (CTTH)
OTCMKTS · Delayed Price · Currency is USD
0.0721
+0.0002 (0.28%)
Jan 20, 2026, 1:03 PM EST
CTT Pharmaceutical Holdings Company Description
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment.
It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.
Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
CTT Pharmaceutical Holdings, Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Ryan Khouri |
Contact Details
Address: 3853 Northdale Blvd Tampa, Florida 33624 United States | |
| Phone | 813-606-0060 |
| Website | cttpharmaceuticals.com |
Stock Details
| Ticker Symbol | CTTH |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US12651E1064 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ryan Khouri | Chief Executive Officer and Director |
| Dr. Pankaj Modi M.D., Ph.D. | Founder and Consultant |
| Marc Lakmaaker | Special Advisor and Senior Vice President of Commercial Development |